Public-registry trials using BBP-418 (ribitol) that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9 | ML Bio Solutions, Inc. | Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) | PHASE3 | 20 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →